Chemoinformaics analysis of CAFFEIC-ACID-4-GLUCOSIDE
| Molecular Weight | 208.213 | nRot | 3 |
| Heavy Atom Molecular Weight | 196.117 | nRig | 8 |
| Exact Molecular Weight | 208.074 | nRing | 1 |
| Solubility: LogS | -1.661 | nHRing | 0 |
| Solubility: LogP | 2.383 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 29.5795 |
| nHD | 2 | BPOL | 14.6425 |
| QED | 0.45 |
| Synth | 2.021 |
| Natural Product Likeliness | 0.809 |
| NR-PPAR-gamma | 0.76 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.019 |
| HIA | 0.009 |
| CACO-2 | -4.62 |
| MDCK | 0.0000226 |
| BBB | 0.197 |
| PPB | 0.922586 |
| VDSS | 0.357 |
| FU | 0.0623616 |
| CYP1A2-inh | 0.964 |
| CYP1A2-sub | 0.186 |
| CYP2c19-inh | 0.513 |
| CYP2c19-sub | 0.081 |
| CYP2c9-inh | 0.612 |
| CYP2c9-sub | 0.868 |
| CYP2d6-inh | 0.424 |
| CYP2d6-sub | 0.671 |
| CYP3a4-inh | 0.457 |
| CYP3a4-sub | 0.246 |
| CL | 15.766 |
| T12 | 0.922 |
| hERG | 0.033 |
| Ames | 0.285 |
| ROA | 0.741 |
| SkinSen | 0.947 |
| Carcinogencity | 0.54 |
| EI | 0.909 |
| Respiratory | 0.161 |
| NR-Aromatase | 0.195 |
| Antiviral | No |
| Prediction | 0.634818 |